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Abstract: Renal diets for advanced chronic kidney disease (CKD) are structured to achieve a lower
protein, phosphate and sodium intake, while supplying adequate energy. The aim of this nutritional
intervention is to prevent or correct signs, symptoms and complications of renal insufficiency, delaying
the start of dialysis and preserving nutritional status. This paper focuses on three additional aspects
of renal diets that can play an important role in the management of CKD patients: the vitamin K1
and fiber content, and the alkalizing potential. We examined the energy and nutrients composition of
four types of renal diets according to their protein content: normal diet (ND, 0.8 g protein/kg body
weight (bw)), low protein diet (LPD, 0.6 g protein/kg bw), vegan diet (VD, 0.7 g protein/kg bw),
very low protein diet (VLPD, 0.3 g protein/kg bw). Fiber content is much higher in the VD and in the
VLPD than in the ND or LPD. Vitamin K1 content seems to follow the same trend, but vitamin K2
content, which could not be investigated, might have a different pattern. The net endogenous acid
production (NEAP) value decreases from the ND and LPD to the vegetarian diets, namely VD and
VLPD; the same finding occurred for the potential renal acid load (PRAL). In conclusion, renal diets
may provide additional benefits, and this is the case of vegetarian diets. Namely, VD and VLPD also
provide high amounts of fibers and Vitamin K1, with a very low acid load. These features may have
favorable effects on Vitamin K1 status, intestinal microbiota and acid-base balance. Hence, we can
speculate as to the potential beneficial effects on vascular calcification and bone disease, on protein
metabolism, on colonic environment and circulating levels of microbial-derived uremic toxins. In the
case of vegetarian diets, attention must be paid to serum potassium levels.
Keywords: Renal diets; Vitamin K1; PRAL; fiber; gut microbiota; uremic toxins; low protein diet;
renal nutrition; metabolic acidosis; CKD
1. Introduction
Nutritional treatment plays a pivotal role in the care of patients affected by chronic kidney disease
(CKD). Dietary interventions aim to reduce the burden of uremic toxins in order to prevent or correct
signs, symptoms and complications of chronic renal insufficiency, thereby delaying the need for
dialysis [1,2].
Healthy dietary patterns, including DASH (Dietary Approaches to Stop Hypertension) diet
and Mediterranean diets, may be useful for CKD prevention or when restriction of phosphate or
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nitrogen load are not necessary or feasible [3–5]. In the early phases of CKD, normalization of protein
(0.8 g/kg/day) and salt (6 g/day) intake are usually implemented with the aim of enhancing the
anti-proteinuric response to renin-angiotensin-aldosterone-system (RAAS) inhibitors, and to prevent
abnormalities of calcium-phosphate metabolism [6].
When renal insufficiency progresses, more specific renal diets are prescribed to reduce uremic toxin
retention, phosphate and sodium load. They include low-protein regimens, namely the conventional,
animal-based low protein (0.6 g/kg/day), or the vegan low protein (0.7 g/Kg/day) diet, or the vegan,
very low protein (0.3 g/kg/day) diet supplemented with essential amino acids and keto-acids [1,7].
These renal diets are based on the control of protein, sodium and phosphate intake, while
preserving nutritional status by high energy intake and adequate essential amino acids supply.
Hence, a progressive protein restriction is highly recommended along with the progression of
renal insufficiency [8,9]; however, this is only one aspect of the dietary management of CKD patients.
Additional features, which are strictly related to protein intake, include changes in sodium, phosphorus
and energy intake, as well as in the source of protein and lipids, namely of animal or plant origin.
A major point is that energy intake must cover the energy requirement (30–35 Kcal/Kg/day), to allow
a correct metabolic adaptation in the course of protein-restricted regimens, thus preventing negative
nitrogen balance [10] and protein-energy wasting.
Apart from these traditional dietary manipulations, dietary supplements may play an important
role in obtaining both beneficial effects and nutritional safety in the CKD patient [11,12]. Essential
amino acids plus ketoacids supplementation is mandatory in the course of a very low-protein diet in
order to assure an adequate essential amino acid supply: the goal is to obtain the beneficial effect of a
severe protein restriction while preventing malnutrition [13,14]. Calcium, iron, Polyunsaturated Fatty
acids (PUFAs) and native Vitamin D represent other types of supplements potentially useful in CKD
patients [11].
However, due to novel evidence in the physiopathology of CKD and its complications, other
non-traditional dietary aspects should be considered in the nutritional management of CKD patients.
This is the case of Vitamin K, fibers and alkali intake.
Vitamin K has a role in the carboxylation of matrix γ-carbossiglutammate (GLA) protein (MGP)
and bone GLA protein (BGP or osteocalcin). Consequently, vitamin K deficiency is associated with an
increased risk of vascular calcifications and bone demineralization [15]. The relative importance of
vitamin K1 (phylloquinone) and K2 (menaquinones) vitamers is still under active investigation [16].
Fiber intake has a major role in the modulation of intestinal microbiota metabolism towards
saccharolytic direction and in lowering proteolytic-derived uremic toxins [17–20]. Moreover, dietary
fibers increase bowel transit. In contrast, constipation, or reduced bowel transit time, worsens
microbiota dysbiosis and contributes to the uremic status and to electrolyte imbalance, namely
hyperkalemia [21].
Reduced dietary acid load is crucial to prevent or correct metabolic acidosis, which plays a
major role in causing protein and amino acid catabolism, along with insulin resistance. Therefore,
metabolic acidosis leads to maladaptation to protein restriction, as well as electrolyte disturbances and
bone damage. In CKD patients, correction of metabolic acidosis may even be important to delay the
progression of renal damage [22].
This paper analyzes the content of Vitamin K1, alkali and fiber of different renal diets used
in pre-dialysis CKD patients, and deals with the importance of these nutrients within the dietary
management of CKD.
2. Materials and Methods
We examined the energy and nutrients composition of four types of renal diets [23] according
to their protein content: normal diet (ND, 0.8 g protein/kg body weight), low protein diet (LPD, 0.6 g
protein/kg bw): vegan diet (VD, 0.7 g protein/kg bw), very low protein diet (VLPD, 0.3 g protein/kg bw).
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For each type of diet, 12 daily meal plans (adapted for a 70 Kg patient) were analyzed and the
results reported as daily average values. The meal plans are provided to the patients in leaflet form
during the nutritional counseling.
Daily meal plans were prepared according to the principles summarized in Table 1, and foods
were selected to ensure an adequate variety across days. Table 1 also shows the main characteristics of
the studied renal diets, according to quantity and source of protein content.
For each of the four diets, we estimated the energy and nutrient intake, namely protein, carbohydrates,
lipids, unsaturated fatty acids, saturated fats, cholesterol, calcium, phosphorus, magnesium, iron, zinc,
copper, fiber, and vitamins A, C, B1, B2, B3, K1, D. Composition data were obtained using the food
composition Tables of the National Institute of Nutrition and of the European Institute of Oncology
Database Edition 2008 [24]. Vitamin K1 content was derived from the “United States Department of
Agriculture (USDA) National Nutrient Database for Standard Reference”, referring to over 900 foods
including foods typical of the Mediterranean diet [25]. Vitamin K2 intake could not be adequately
estimated for lack of reference tables and for the difficulty in determining its intestinal synthesis by
the microbiota.
The daily energy and nutrients intake were reported as average of the 12 day meal plans for
each type of diet. We also calculated the potential renal acid load (PRAL) and the net endogenous
acid production (NEAP). These parameters represent the non-volatile acid load derived from the diet,
estimated by the production of non-volatile acids and bases produced during digestion based on
known nutritional content.
PRAL was calculated by the following formula as described by Remer and Manz [26]:
PRAL (mEq/day) = (0.49 × protein, g/day) + (0.037 × phosphorus, mmol/day) −
(0.021 × potassium, mmol/day) − (0.026 × magnesium, mg/day) − (0.013 × calcium, mg/day).
NEAP was calculated by the formula described by Frassetto et al. [27].
NEAP(mEq/day) = (54.5 × protein (g/day)/potassium, (mmol/day)) − 10.2.
Statistical Analysis
Statistical analysis was performed using SPSS 19.0 (SPSS Inc, Illinois, USA) the company, the city,
the country) for Windows. Data are expressed as mean ± standard deviation or as median and
interquartile range when appropriate.
Intra- and intergroup statistical comparisons of nutrients and energy content of the four diets were
performed using one-way Analysis of Variance (ANOVA) and the Bonferroni post hoc test. Differences
were considered to be statistically significant when p < 0.05.
3. Results
Table 1 shows the main characteristics of the studied renal diets.
Table 2 reports the energy and nutrients content of the studied renal diets. Significantly different
levels of protein, phosphorus and sodium content are the main features of the diets.
Table 3 shows the fiber, potassium, magnesium and vitamin K1 content of the dietary patterns for
CKD patients, normalized per 1000 Kcal. The fiber content is much higher in the VD and in the VLPD
than in the Normal diet ND or in the LPD. The vitamin K1 content also seems to follow this trend.
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Table 1. General characteristics of the four renal diets (Ref. [23]), according to quantity and source of protein content.
Normal Diet Low Protein Diet Vegan Diet Very Low Protein Diet
Grains (bread, pasta, rice,
barley, etc.)
6–8 servings per day: e.g., 1 serving
at breakfast, 2 servings at lunch and
dinner, 1 serving at snack
Replaced by protein-free products.
6–8 servings per day: e.g., 1 serving
at breakfast, 2 servings at lunch and
dinner, 1 serving at snack
6–8 servings per day: e.g., 1 serving
at breakfast, 2 servings at lunch and
dinner, 1 serving at snack
Replaced by protein-free products.
1 serving per day of grains is allowed
to give variety to the diet. The amount
is defined to obtain a daily protein
intake of 0.3 g protein/kg body weight
Vegetables and fruits * 4–5 servings per day with suggestion
to control potassium level
4–5 servings per day with suggestion
to control potassium level
4–5 servings per day with suggestion
to control potassium level
More than 4–5 servings per day with
suggestion to control potassium level
Meat and Poultry 1 serving 1–2 times per week in the
amount defined by the dietitian
1 serving per day as they represent
the only source of proteins with high
biological value. The daily amount is
defined according to ideal/adjusted
body weight and clinic
Excluded Excluded
Fish 1 serving 2–3 times per week in the
amount defined by the dietitian
Used as an alternative to meat
and poultry
Excluded Excluded
Beans (beans, chickpeas,
peas, lentils, etc.)
At least 3 servings per week as a
substitute for meat, fish etc., together
with grains and not as a side dish
1–2 servings per week use together
with rice, corn or regular bread and
pasta (not with protein free products)
1 serving per day. Mandatory at least
in one meal
1 serving 2–3 times per week,
the amount is defined to obtain a daily
protein intake of 0.3 g protein/kg body
weight
Dairy products 1 serving of soft cheese
(i.e., Mozzarella or ricotta cheese)
every 7–10 days; 1 serving per day of
milk or yogurt is allowed according
to patient’s clinic. Avoid hard cheese
Excluded Excluded Excluded
Eggs 1 whole egg every 7–10 days. 2 egg
whites in place of 35 g of meat or 50 g
of fish 1–2 times per week
2 egg whites in place of 35 g of meat
or 50 g of fish
Excluded Excluded
Oil and fats # Olive oil intake is preferable in
respect to animal fats
Olive oil intake is preferable in
respect to animal fats
Olive oil intake is preferable in
respect to animal fats
Olive oil intake is preferable respect to
animal fats
Jam, marmalade, honey, sugar are allowed to increase energy content with the exception for diabetes, overweight or obesity. Butter or cream are allowed in the case of poor appetite or to
improve food palatability and energy intake Importantly, VLPD does not cover the necessary daily amount of essential amino-acids, inducing the need for a supplementation with specific
products, namely amino-acids and keto-acids. * In the case of hyperkalemia: reduce the number of servings, select fruits, use boiling. # Reduce the number of servings in the case of
overweight/obesity.
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Table 2. Energy and nutrients content of the four studied renal diets.
ND LPD VD VLPD p
Energy, Kcal 1995 ± 63 2234 ± 123 a 2190 ± 88 b 2166 ± 197 c <0.001
Protein, g 57.6 ± 2.4 42.4 ± 2.5 a 45.9 ± 3.5 b,d,e 20.0 ± 3.2 c,f <0.001
Animal protein, g 16.8 ± 7.4 26 ± 9.6 a 0.9 ± 1.6 b,d 0.6 ± 1.0 c,f <0.001
Vegetable protein, g 35.0 ± 6.4 11 ± 3.5 a 45 ± 5.5 b,d,e 19.1 ± 1.9 c,f <0.001
Total fat, g 72.5 ± 5.4 91 ± 13 a 79 ± 9.8 84 ± 14 <0.01
Saturated fat, g 14.6 ± 3.7 19 ± 5.4 17.4 ± 6.6 17 ± 4.5 n.s.
Unsaturated fat, g 50.7 ± 3.5 55.6 ± 8.2 55.4 ± 8.7 52 ± 11 n.s.
Cholesterol, mg 105 ± 83 107 ± 21 34 ± 39 b,d 38 ± 29 c,f <0.01
Total carbohydrates, g 297 ± 16.4 331 ± 40 341 ± 23 351 ± 41 <0.01
Sugars, g 93.0 ± 11.4 84 ± 18 96 ± 11 104 ± 10 f <0.01
Starch, g 194 ± 11 172 ± 36 235 ± 18 b,d,e 176 ± 50 <0.001
Fiber, g 28 ± 4.6 17 ± 3.4 35 ± 4.2 b,d,e 25 ± 4.6 f <0.001
Sodium, mg 649 ± 185 410 ± 229 647 ± 653 303 ± 218 n.s.
Potassium, mg 2265 ± 406 1969 ± 268 3152 ± 685 b,d 2590 ± 645 f <0.001
Calcium, mg 476 ± 136 192 ± 53 a 334 ± 73 b 317 ± 74 c,f <0.001
Phosphorus, mg 884 ± 85 531 ± 72 a 745 ± 56 b,d,e 428 ± 87 c,f <0.001
Magnesium, mg 179.5 ± 37.1 109.5 ± 31.8 248.5 ± 56.9 b,d,e 160.6 ± 72.1 <0.001
Iron, mg 9.60 ± 1.44 5.91 ± 1.23 a 10.5 ± 1.65 c,d,f 7.15 ± 2.20 <0.01
Copper 2.18 ± 1.45 1.10 ± 0.52 1.68 ± 0.93 1.55 ± 1.15 n.s.
Zinc, mg 6.40 ± 0.50 5.46 ± 1.38 5.36 ± 0.87 3.31 ± 1.11 c,e,f <0.001
Vitamin K1, µg 381.3 ± 220.2 185.7 ± 151.2 447.3 ± 410.0 441.6 ± 463.8 n.s.
Vitamin A, µg 590.3 ± 232.5 562.2 ± 384.5 951.4 ± 829.4 1214 ± 970.1 n.s.
Vitamin D, µg 0.52 ± 0.48 0.71 ± 0.66 0.51 ± 0.66 0.22 ± 0.27 n.s.
Vitamin B12, µg 1.51 ± 0.80 2.16 ± 1.42 0.03 ± 0.05 b,d 0.02 ± 0.03 c,f <0.001
ND: normal diet (0.8 g protein/kg body weight); LPD: low protein diet (0.6 g protein/kg body weight); VD: vegan
diet (0.7 g protein/kg body weight); VLPD: very low protein diet (0.3 g protein/kg body weight). Superscript letters
indicate p < 0.05. a: LPD vs. ND; b: VD vs. ND; c: VLPD vs. ND; d: VD vs. LPD; e: VLPD vs. VD; f: VLPD vs. LPD.
n.s.: not significant.
Table 3. Fiber, potassium, magnesium and Vitamin K1 content of the dietary patterns for chronic
kidney disease (CKD) patients, as normalized per 1000 Kcal.
ND LPD VD VLPD p
Fiber, g/1000 Kcal 10.4 ± 2.27 7.66 ± 1.60 a 15.9 ± 2.21 d,e 11.4 ± 2.15 c,f 0.001
Vitamin K1, µg/1000 Kcal 190.8 ± 108.9 82.3 ± 65.6 206.5 ± 192.2 200.6 ± 203.1 n.s.
Potassium, mg/1000 Kcal 1135 ± 201.2 884.1 ± 132.8 1440 ± 306.3 b,d 1200 ± 294.1 f 0.001
Magnesium, mg/1000 Kcal 90.0 ± 18.9 49.2 ± 14.6 a 113.4 ± 25.5 d,e 74.5 ± 32.9 0.001
ND: normal diet (0.8 g protein/kg body weight); LPD: low protein diet (0.6 g protein/kg body weight); VD: vegan
diet (0.7 g protein/kg body weight); VLPD: very low protein diet (0.3 g protein/kg body weight). Superscript letters
indicate p < 0.05. a: LPD vs. ND; b: VD vs. ND; c: VLPD vs. ND; d: VD vs. LPD; e: VLPD vs. VD; f: VLPD vs. LPD.
The net endogenous acid production (NEAP) value decreases from the normal diet to the
vegetarian diets, namely VD and VLPD (Figure 1).
We calculated the potential renal acid load (PRAL) value to compare the acidic/alkalizing power
of the four dietary patterns and, as expected, it decreases from the normal diet to the vegetarian diets
(Figure 1).
Regarding the magnesium content, only the VD covers the levels of 240 mg/day recommended
for the adult general population, due to legumes and grains that are highly represented in this diet.
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Figure 1. The Potential renal acid load (PRAL) and the net endogenous acid production (NEAP) of the
four studied renal diets, expressed as mEq/day. ND: normal diet (0.8 g protein/kg body weight); LPD:
low protein diet (0.6 g protein/kg body weight); VD: vegan diet (0.7 g protein/kg body weight); VLPD:
very low protein diet (0.3 g protein/kg body weight).
4. Discussion
The common western dietary habits are excessively rich in protein and low in fruit and vegetables,
grains, and fibers, considering the recommendations of the World Health Organization WHO for the
general population [28]: 0.83 g of proteins/Kg/day, 6 grams/day of sodium chloride and 700 mg/day
of phosphorus. Actually, the usual protein intake is over 1.2 g proteins/kg/day, the salt intake largely
overcome 10–12 g/day , and phosphorus is higher than 1200–1700 mg/day. Thus, it is not surprising
that prescription of a “normal” diet, that is a diet covering the WHO recommendations, may be a
successful first-step intervention able to reduce sodium load, nitrogen waste product retention and
calcium-phosphate metabolism abnormalities.
While adopting healthy dietary patterns, such as the DASH or Mediterranean diets, may be
useful as a prevention strategy in a population-based setting, specific renal diets aimed at protein,
sodium and phosphorus controlled intake may be needed in advanced stages of renal insufficiency.
The aim of nutritional treatment in advanced CKD is to prevent or correct signs, symptoms of chronic
renal failure, prevent protein energy wasting (PEW) and delay the start of dialysis by reducing toxin
retention, mainly derived by catabolism of dietary protein load. This is the reason why dietary
manipulation in renal patients is historically related to protein intake, which is strictly linked to
sodium and phosphorus intake.
This paper focused on additional aspects, namely vitamin K1 and fiber content, and alkalizing
power of these renal diets, factors that can play an important role in the management of CKD patients.
The fiber content is quite high in VD and VLPD (Table 3) and it meets the recommended level of
20–30 g/day for CKD patients [29] both in the VD and in the VLPD (Table 4).
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Table 4. Recommended levels of nutrients intake of fiber, Vitamin K1, potassium and magnesium, for
the general population in Italy (Livelli di Assunzione Raccomandata di Nutrienti, LARN) (ref. no. [29])
and by the National Kidney Foundation (NKF) (ref. no. [30]).
LARN NKF
General Population CKD(stage 1–5 ND) HD PD
Fiber 12.6–16.7 g/1000 kcal 20–30 g/day 20–25 g/day 20–25 g/day
Vitamin K 30–59 years : 140 µg/day>60 years: 170 µg/day 90–120 µg/day (10 mg/day with antibiotic therapy)
Potassium 3.9 g/day Unrestricted unlessserum level is high
Up to 2.7–3.1 g/day;
adjust to serum levels
3–4 g/day; adjust
to serum levels
Magnesium 240 mg/day Not available 200–300 mg/day Not available
Interestingly, the food industry, in response to increased consumer sensitivity to health topics, is
becoming more attentive to fiber content in processed food. Moreover, in the context of protein-free
food products specific for CKD patients, in the last year more fibers have been added to regular
and even to the protein-free bread or pasta with the aim to reduce the glycemic index, as well as for
technological purposes. In particular, the addition of inulin modulates microbiota metabolism and the
high fiber intake of vegan diet may have favorable effects on intestinal microbiota.
A great bulk of literature is highlighting the dynamic link between gut microbiota and the human
body pathophysiology, including kidneys and the CKD status [31,32]. Beyond the microbiota activity
affecting the whole organism at a systemic level, the gut-kidney axis presents a particularly intimate
connection [31].
The microbiota affects human pathophysiology through its metabolites, derived from the
saccharolytic (fermenting complex carbohydrates) or the proteolytic (using aminoacids as alternative
substrate for energy harvesting) catabolism of food reaching the colon [33]. While the former is
believed to be a “beneficial” pathway thanks to the downstream metabolites (mainly Short Chain
Fatty Aminoacids—SCFAs) with anti-inflammatory, immune-modulating and gut integrity-promoting
action [34], an unbalance towards the latter is noxious because it results in overproduction of many
toxic metabolites, such as amines, indoles, phenols, hydrogen sulphide and secondary bile acids [33,35].
For this reason, a “healthy gut” possesses a metabolism that is mainly saccharolytic [33,36].
Moreover, uremia impacts the colonic environment exacerbating the dysbiosis status already
present in CKD patients, often caused by dietary restrictions in fiber content [37] and altered
assimilation of proteins in the intestine, leading to increased availability of colonic amino acids
as fermentation substrates [38,39]. In a situation of impaired kidney filtration capacity, the colon
acquires a replacement role for the excretion of urea and oxalate: this process alters colonic pH and
promotes the overgrowth of potentially pathogenic, proteolytic microbial species, leading to a further
increase of uremic toxins production, in a vicious circle [33].
Another pathologic aspect often observed in CKD patients is the “leaky gut” syndrome. Alteration
of gut microenvironment, beyond promoting dysbiosis, causes the derangement of colonic epithelial
barrier, leading to gut permeability. A leaky gut allows translocation to the circulation of bacteria
and microbial fragments, such as bacterial lipopolysaccharides (LPS). This phenomenon is believed
to trigger low-grade systemic inflammation, worsening a clinical frame already compromised by
uremia [40].
The good news is that microbiota metabolism is susceptible of manipulation by dietary matrices.
Diets abundant in fiber-rich foods (fruits, vegetables and legumes), such as the Mediterranean or
purely vegetarian diets, have the potential to shift the microbial metabolism in saccharolytic direction,
with the release of SCFAs and the reduction of uremic toxins [19,20,33].
Unfortunately, current dietary management of CKD patients often foresees a strict restriction of
most fruits, vegetables and legumes, corresponding to the richest suppliers of dietary fibers. This
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indication, although justified by the need to control potassium levels, leads to deleterious effects for
the colonic health and worsens the microbiota dysbiosis typical of the uremic patient.
Scientific evidence suggests that this tendency should be reverted. Fiber intake in the dietary
management of CKD should be encouraged for its ability to modulate microbiota metabolism in
saccharolytic direction and to lower proteolytic-derived uremic toxins [17–20]. Moreover, fibers
increase bowel transit, which is desirable in CKD patients. Reduced bowel transit worsens microbiota
dysbiosis and contributes to the uremia status and to electrolyte imbalance [21]. It is meaningful that,
in an animal study, even treating the constipation alone with a pharmacologic approach resulted in
microbial probiotic species recovery, and circulating microbial toxins reduction [41].
Increased fiber intake could also be beneficial for gut permeability. Some studies indicate that
SCFAs, saccharolytic metabolites, could be able to promote the epithelial integrity [42], even though
this aspect remains to be demonstrated in vivo and is worthy of being investigated in clinical trials.
In the four diets we examined, the NEAP and the PRAL values were significantly lower in
vegetarian diets, namely VD and VLPD, than in ND.. The PRAL value of the VD is consistent with
what reported in the literature (−26.9 ± 15.4 mEq/day in respect to an average value of −20 mEq/day
of a Vegan diet). The PRAL of the VLPD is 37.6% higher than that of the VD. These results were
expected, as PRAL depends on protein, phosphate, potassium, calcium and magnesium content of the
diet. The PRAL of what we defined a “normal diet” is lower than that reported for a current typical
western diet, rich in animal proteins (approximately +50 mEq/day). In fact, plant proteins present
in the ND are twice that of the animal proteins and the adequate amount of essential amino acids is
guaranteed by the consumption of animal proteins alternate to that of legumes combined to grains,
according to the principle of complementarity of proteins. The presence of grains and pulses (together
with 4–5 servings of vegetables per day and a phosphate content according to the Recommended
Dietary Allowance with the exclusion of cheese) contributes to reduce the PRAL value.
The LPD has a higher amount of animal proteins in comparison to the ND, to counteract the
presence of protein-free products and to guarantee an adequate amount of essential amino acids.
However, the reduction of total protein intake and phosphate content and the presence of fruit and
vegetables contribute to an overall alkalizing effect, even if it is weaker than in vegetarian diets.
The VD induces a remarkable alkalizing effect due to the exclusive presence of plant foods. Most
fruit and vegetables are known to produce alkali when metabolized, contributing to acid neutralization.
However, they also contain organic acids (i.e., citric acid) and organic salts as potassium citrate.
The organic acids produce hydrogen ions (H+) and basic ions when metabolized, while organic salts
have a basic ion but no H+ so they can buffer H+ reducing the acid load. Phosphate content in the VD
is higher than that of the LPD but it is prevalently in the form of phytate, thus scarcely absorbable.
The VLPD has the higher negative PRAL value and therefore its alkalizing power is very high:
this is due to its low protein content, all from plant origin, and the larger amount of vegetables that
contribute to the variety of the diet.
Moreover, these dietary patterns are characterized by a low salt content, as these patients are
usually asked by the nephrologist to reduce added salt and to avoid processed foods. This contributes
to reduce the acid load, as salt independently increases acid load and reduces serum bicarbonate [43].
A more alkaline diet lowers NEAP and reduces the acid load, contributing to a reduced stimulation
of aldosterone, angiotensin II and endothelin, which are involved in dietary acid excretion [22]. In CKD
patients a diet rich in fresh fruits and vegetables can control metabolic acidosis similarly to sodium
bicarbonate administration [22]. In addition, the VLPD supplemented with EAA and KA reduces
metabolic acidosis in patients with advanced CKD [44].
Prevention and correction of metabolic acidosis has paramount importance for limitation of
protein and aminoacid catabolism, protection of renal function and reducing the risk of hyperkalemia,
hyperphoshatemia and bone mineral loss.
Thus, VD and VLPD, being vegetarian in nature, have high fiber content, low net acid production
and high potassium intake. These are favorable features, but the potassium dietary burden is also
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relevant concern in CKD patients, and it deserves comments [45]. In patients with preserved renal
function and urine volume output, a relevant capacity to excrete potassium by urine still persists.
In addition, a significant fecal excretion contributes to maintenance of K balance. Fecal excretion is
especially important in dialysis patients, where hyperkalemia seems to be related to both constipation
and dietary load [21]. Other relevant causes of hyperkalemia are drugs and acidosis, favoring the shift
of potassium from intracellular to extracellular fluids.
Attention must be paid to serum potassium levels in patients on vegetarian diets. Although high
dietary intake is not the main pathogenic factor of hyperkalemia, limitation of excess potassium load
and cooking strategies should be implemented, together with close monitoring of serum potassium
levels [45]. However, it is noteworthy that the increased risk of hyperkalemia due to high potassium
load on vegetarian diets can be counteracted by the better correction of metabolic acidosis and the
increased intestinal transit due to vegetarian diet. In CKD patients, no changes in serum potassium
was observed using a vegan or an animal-based low-protein diet [46]. Similarly, during high-fruit
intake, no hyperkalaemia episodes were reported [22].
The capacity of the colon/rectum to secrete potassium is inversely related to the residual
renal function, and it substantially contributes to potassium homeostasis in patients with CKD.
A pharmacological approach to hyperkalemia is another effective approach to counterbalance potassium
overload in CKD [47].
The adoption of a plant-based diet such as the vegan or the very low-protein diet has positive
effects on the bowel status, reducing the microbial catabolites originated by protein intestinal
fermentation. In particular, p-cresyl sulfate, indoxyl-sulfate and TMAO (Trimethylamine N-oxide,
an organic compound in the class of amine oxides), are reduced by protein restriction [48–50]. Moreover,
increasing the fiber content in a diet has a modulating effect on gut microbiota composition, reducing
protein fermentative processes and proteolytic metabolites [19,20].
The effects of diet on vitamin K status has been investigated for many years [51], but with
non-definitive results. It should be always kept in mind that vitamin K status is dependent not only
through dietary intake, but also intestinal bacterial synthesis, the endogenous recycling mechanisms
and the interference of drugs, particularly warfarin, on the vitamin K cycle [52]. In addition, studies
investigating dietary content of vitamin K should consider both phylloquinone (vitamin K1) and
menaquinones (vitamin K2) content and only some of the available studies did so.
Vitamin K has been favorably associated with various health outcomes, including diabetes [53],
non-fatal cardiovascular diseases [54,55] and cancer [56]. The association between vitamin K intake
and mortality has also been investigated. In a Dutch cohort of 33,289 participants with normal
renal function, aged 20–70 years at baseline with a mean follow-up of 16.8 years, phylloquinone and
menaquinones dietary intake was assessed with a food frequency questionnaire: vitamin K intake was
not associated with all-cause mortality, cancer mortality and mortality from other causes [57]. On the
other hand, an increase in dietary intake of vitamin K was found to be associated with a reduced
risk of cardiovascular disease, cancer, or all-cause mortality in a Mediterranean population at high
cardiovascular disease risk [58]. Similarly, vitamin K intake was associated with reduced mortality in
people with chronic kidney disease [59].
Vitamin K is present in humans under different forms: vitamin K1 (phylloquinone, PK) and
multiple K2 (menaquinones, MKs) vitamers which are classified according to the length of their
unsaturated side chains. PK is found in green leafy vegetables. In particular, the best food sources of
PK are cabbage kimchi, spinach, spring onions and soybean oils. Vitamin K2 is contained in cheese
and fermented foods, such as natto (fermented soybean, common in Japan). Natto contains mainly
MK-7, then MK-8 and PK in modest concentration. Usually, 75% to 90% of total vitamin K intake
comes from PK, 10% to 25% derives from MKs. Importantly, MKs are also produced by intestinal
bacterial fermentation. Considering that in the CKD population, a gut microbiota dysbiosis is present,
a defective production of MKs may also occur [33].
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Bacterial menaquinones present in the colon are mainly MK-10 and MK-11, synthesized by
Bacteroides, MK-8 by Enterobacteria, MK-7 by Veillonella, and MK-6 by Eubacterium lentum [60].
Menaquinone-4 (MK-4) is the only one not derived by bacterial origin but by a direct conversion of
dietary PKs [60].
PK content is quite high in all four renal diets considered here and largely covers the adequate
intake of vitamin K for the general population that in Italy is set at 140 mcg/day between 30 and
59 years and 170 mcg/day over 60 years [29]. In 2001, the US Food and Nutrition Board suggested
120 mcg/day for adult males and 90 mcg/day for adult females [61]. The dietary PK content is strictly
dependent on the variety of vegetables. In the planning of the daily meals of the four renal diets
considered here the variability of vegetables was the same. The higher content of PK on VD and
VLPD is due to a greater amount of vegetables. This is also the reason for the higher potassium load
of VD and VLPD, although it does not exceed the WHO recommended minimum daily intake of
90 mmol/day (Table 4).
In the clinical setting, we found a remarkably low PK dietary intake in hemodialysis patients,
2-fold lower than the median intake suggested by RDAs for the Italian population [62]. An increase in
vegetable foods as outlined in the VD could correct PK deficiency, both in CKD patients and in the
general population, improving bone and vascular health. In particular, bone fractures are a common
and remarkable complication in CKD patients [63]. In the large and diverse international DOPPS study,
Tentori et al. [64] described a lower incidence of fractures in the Japanese population, where MKs
dietary intake is high due to a large consumption of natto. Consistently, we found that PK deficiency
was the strongest predictor of vertebral fractures in hemodialysis patients [65]. Prevalence of vertebral
fractures was 55%, with a significant association between severity of fractures and lower levels of
total BGP [66]. Currently, there is very little literature on the role of vitamin K supplementation
in osteoporosis prevention in men and women. Osteoporosis, predisposing to an increased risk of
fracture, is characterized by compromised bone strength, which is a result of two integrated main
features, bone mineral density and bone quality. Although poor vitamin K status has been linked to
osteoporosis in observational studies, no changes in bone mineral density were observed after PK
supplementation [59]. However, Cheung et al. [67] described a lower incidence of clinical fractures
among women treated with PK at the dose of 5 mg/day, despite a lack of effect on bone mineral density
and reabsorption. Therefore, vitamin K could act on bone quality, in particular on microarchitecture or
on mineralization patterns mediated by BGP action, rather than on bone mass density. In Japan, MK-4
is considered an effective drug for osteoporosis care, as it was shown to prevent fractures [68].
Although the MKs production by intestinal microbiota cannot be quantified, it might have a
significant effect on bone and vascular health. Future studies should evaluate if diets rich in vegetables
with prevalent intake of PK can influence the long chain MKs producing bacterial flora. Animal food
rich in MKs could also contribute in improving the activity of vitamin K dependent proteins [69].
Neither the vegan diet nor a very low-protein diet include food from animal origin and they
are therefore poor in vitamin B12 and in highly bio-available iron. These are the most important
shortcomings of vegan/vegetarian diets. In the case of long-term treatment, preparations containing
iron or vitamin B12 must be supplemented. Another potential shortcoming may be related to a
potential lack of essential amino acids. However, a careful combination of pulses and cereals may give
an adequate essential amino acids supply, enough to guarantee a positive nitrogen balance [46]; in the
case of the very low-protein diet, supplementation of essential amino acids and ketoacids is mandatory
to maintain a good nutritional status [70]. In addition, the exclusion of food of animal origin could
determine a zinc deficiency. Zinc content in food of plant origin is lower than that of food of animal
origin and scarcely absorbable do to the presence of fibers and phytate. Recently, it has been reported
that zinc deficiency is seen in CKD patients and that heavy metal deficiency including zinc deficiency
is one of the causes of Erythropoietin-resistant anemia [71]. Moreover, zinc deficiency is known to
affect taste that is one of the most important factors in food choice, selection and consumption and it
can affect appetite leading to dietary restrictions that could negatively impact nutritional and health
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status [72]. Hence, iron status, VitB12 zinc levels should be monitored in CKD patients in general and
in particular in the elderly and in those following a vegan or very low protein diet for a long time.
5. Conclusions
In conclusion, renal diets for advanced chronic renal insufficiency are structured to achieve
the main goal of lowering protein, phosphate and sodium intake, while supplying adequate energy.
The aim is to prevent or correct signs, symptoms and complications of renal insufficiency, delaying the
start of dialysis and preserving nutritional status. Furthermore, renal diets may provide additional
benefits, and this is the case for vegetarian diets. Namely, VD and VLPD also provide high amounts of
fiber and Vitamin K1, with a very low acid load. These features may have favorable effects on Vitamin
K status, intestinal microbiota and acid-base balance. Hence, we can speculate potential beneficial
effects on vascular calcification and bone disease, on colonic environment and on protein metabolism.
In the case of vegetarian diets, attention must be paid to serum potassium levels.
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